{"id":5989,"date":"2017-02-13T09:00:00","date_gmt":"2017-02-13T09:00:00","guid":{"rendered":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/deelnemen-aan-onderzoek\/"},"modified":"2025-05-27T12:11:07","modified_gmt":"2025-05-27T10:11:07","slug":"deelnemen-aan-onderzoek","status":"publish","type":"post","link":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/deelnemen-aan-onderzoek\/","title":{"rendered":"Deelnemen aan onderzoek"},"content":{"rendered":"<img loading=\"lazy\" decoding=\"async\" class=\"alignright size-thumbnail wp-image-7115\" src=\"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/09\/shutterstock_298879511-150x150-2.jpg\" alt=\"\" width=\"150\" height=\"150\" \/>Het onderzoek wat dankzij Breakthrough T1D wordt uitgevoerd is veelbelovend voor mensen met Type 1 Diabetes. Dat zorgt ervoor dat we veel vragen krijgen van mensen die als proefpersoon willen deelnemen aan onderzoeken naar slimme insuline, de kunstmatige alvleesklier en alle andere onderzoeken. Bij dezen zetten we de onderzoeken die in Nederland proefpersonen zoeken voor je op een rij. Let op: deze lijst wordt regelmatig ge-update, maar het kan zijn dat een onderzoek al klaar is met het verzamelen van proefpersonen. Laat dat dan vooral aan ons weten.\n<ul><li><a href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02460978?term=type+1+diabetes&amp;recr=Open&amp;cntry1=EU%3ANL&amp;rank=2\"><strong>Dapagliflozin Evaluation in Patients With Inadequately Controlled Type 1 Diabetes (DEPICT 2)<\/strong><\/a><\/li>\n \t<li><a href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02733991?term=type+1+diabetes&amp;recr=Open&amp;cntry1=EU%3ANL&amp;rank=3\">Study of MiniMed\u2122 640G Insulin Pump With SmartGuard\u2122 in Prevention of Low Glucose Events in Adults With Type 1 Diabetes (SMILE)<\/a><\/li>\n \t<li><a href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02580591?term=type+1+diabetes&amp;recr=Open&amp;cntry1=EU%3ANL&amp;rank=4\">Empagliflozin as Adjunctive to Insulin Therapy Over 26 Weeks in Patients With T1DM (EASE-3)<\/a><\/li>\n \t<li><a href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02411253?term=type+1+diabetes&amp;recr=Open&amp;cntry1=EU%3ANL&amp;rank=5\">Low-dose rhIL-2 in Patients With Recently-diagnosed Type 1 Diabetes (DIABIL-2)<\/a><\/li>\n \t<li><a href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02844517?term=type+1+diabetes&amp;recr=Open&amp;cntry1=EU%3ANL&amp;rank=7\">International Diabetes Closed Loop (iDCL) Trial: Research Site Training Protocol<\/a><\/li>\n \t<li>The influence of food order on postprandial blood glucose levels in children with type 1 diabetes.<\/li>\n \t<li>Cognitive behaviour therapy delivered by internet for chronic fatigue in type 1 diabetes: a randomized controlled trial<\/li>\n<\/ul>\nBron: Clinicaltrials.gov, trialnet.gov.\n\n<span><strong>Disclaimer:<\/strong><\/span> Veel van deze onderzoeken hebben erg strenge eisen als het gaat om de mensen die als proefpersoon deel kunnen nemen. HbA1c, leeftijd, geslacht en allerlei andere factoren spelen daarin een rol. Houd daar dus rekening mee alvorens je je aanmeldt voor een onderzoek: de kans is aanwezig dat je niet deel kunt nemen. Breakthrough T1D kan hier geen invloed op uitoefenen.","protected":false,"raw":""},"excerpt":{"rendered":"<p>Het onderzoek wat dankzij Breakthrough T1D wordt uitgevoerd is veelbelovend voor mensen met Type 1 Diabetes. Dat zorgt ervoor dat we veel vragen krijgen van mensen die als proefpersoon willen deelnemen aan onderzoeken naar slimme insuline, de kunstmatige alvleesklier en alle andere onderzoeken. Bij dezen zetten we de onderzoeken die in Nederland proefpersonen zoeken voor [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[184],"tags":[],"class_list":["post-5989","post","type-post","status-publish","format-standard","hentry","category-archief"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.3 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Deelnemen aan onderzoek - Breakthrough T1D<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/deelnemen-aan-onderzoek\/\" \/>\n<meta property=\"og:locale\" content=\"nl_NL\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Deelnemen aan onderzoek - Breakthrough T1D\" \/>\n<meta property=\"og:description\" content=\"Het onderzoek wat dankzij Breakthrough T1D wordt uitgevoerd is veelbelovend voor mensen met Type 1 Diabetes. Dat zorgt ervoor dat we veel vragen krijgen van mensen die als proefpersoon willen deelnemen aan onderzoeken naar slimme insuline, de kunstmatige alvleesklier en alle andere onderzoeken. Bij dezen zetten we de onderzoeken die in Nederland proefpersonen zoeken voor [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/deelnemen-aan-onderzoek\/\" \/>\n<meta property=\"og:site_name\" content=\"Breakthrough T1D\" \/>\n<meta property=\"article:published_time\" content=\"2017-02-13T09:00:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-05-27T10:11:07+00:00\" \/>\n<meta name=\"author\" content=\"ylt-admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Geschreven door\" \/>\n\t<meta name=\"twitter:data1\" content=\"ylt-admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Geschatte leestijd\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minuut\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/deelnemen-aan-onderzoek\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/deelnemen-aan-onderzoek\/\"},\"author\":{\"name\":\"ylt-admin\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/person\/c141fde9814deb17e9eb392bdb6619a6\"},\"headline\":\"Deelnemen aan onderzoek\",\"datePublished\":\"2017-02-13T09:00:00+00:00\",\"dateModified\":\"2025-05-27T10:11:07+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/deelnemen-aan-onderzoek\/\"},\"wordCount\":254,\"publisher\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#organization\"},\"image\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/deelnemen-aan-onderzoek\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/09\/shutterstock_298879511-150x150-2.jpg\",\"articleSection\":[\"Archief\"],\"inLanguage\":\"nl-NL\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/deelnemen-aan-onderzoek\/\",\"url\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/deelnemen-aan-onderzoek\/\",\"name\":\"Deelnemen aan onderzoek - Breakthrough T1D\",\"isPartOf\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/deelnemen-aan-onderzoek\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/deelnemen-aan-onderzoek\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/09\/shutterstock_298879511-150x150-2.jpg\",\"datePublished\":\"2017-02-13T09:00:00+00:00\",\"dateModified\":\"2025-05-27T10:11:07+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/deelnemen-aan-onderzoek\/#breadcrumb\"},\"inLanguage\":\"nl-NL\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/deelnemen-aan-onderzoek\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/deelnemen-aan-onderzoek\/#primaryimage\",\"url\":\"\",\"contentUrl\":\"\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/deelnemen-aan-onderzoek\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/breakthrought1d.eu\/nl\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Deelnemen aan onderzoek\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#website\",\"url\":\"https:\/\/breakthrought1d.eu\/nl\/\",\"name\":\"Breakthrough T1D\",\"description\":\"Wij zetten ons in voor een toekomst zonder T1D\",\"publisher\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/breakthrought1d.eu\/nl\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"nl-NL\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#organization\",\"name\":\"Breakthrough T1D\",\"url\":\"https:\/\/breakthrought1d.eu\/nl\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/11\/BTlogo.png\",\"contentUrl\":\"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/11\/BTlogo.png\",\"width\":330,\"height\":141,\"caption\":\"Breakthrough T1D\"},\"image\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/person\/c141fde9814deb17e9eb392bdb6619a6\",\"name\":\"ylt-admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/67a3317a8082bc0f586c2e46f82a1617530cf674f2027a1a7d60fdff63a2c3e8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/67a3317a8082bc0f586c2e46f82a1617530cf674f2027a1a7d60fdff63a2c3e8?s=96&d=mm&r=g\",\"caption\":\"ylt-admin\"},\"sameAs\":[\"https:\/\/87.250.144.92\"],\"url\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/author\/ylt-admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Deelnemen aan onderzoek - Breakthrough T1D","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/deelnemen-aan-onderzoek\/","og_locale":"nl_NL","og_type":"article","og_title":"Deelnemen aan onderzoek - Breakthrough T1D","og_description":"Het onderzoek wat dankzij Breakthrough T1D wordt uitgevoerd is veelbelovend voor mensen met Type 1 Diabetes. Dat zorgt ervoor dat we veel vragen krijgen van mensen die als proefpersoon willen deelnemen aan onderzoeken naar slimme insuline, de kunstmatige alvleesklier en alle andere onderzoeken. Bij dezen zetten we de onderzoeken die in Nederland proefpersonen zoeken voor [&hellip;]","og_url":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/deelnemen-aan-onderzoek\/","og_site_name":"Breakthrough T1D","article_published_time":"2017-02-13T09:00:00+00:00","article_modified_time":"2025-05-27T10:11:07+00:00","author":"ylt-admin","twitter_card":"summary_large_image","twitter_misc":{"Geschreven door":"ylt-admin","Geschatte leestijd":"1 minuut"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/deelnemen-aan-onderzoek\/#article","isPartOf":{"@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/deelnemen-aan-onderzoek\/"},"author":{"name":"ylt-admin","@id":"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/person\/c141fde9814deb17e9eb392bdb6619a6"},"headline":"Deelnemen aan onderzoek","datePublished":"2017-02-13T09:00:00+00:00","dateModified":"2025-05-27T10:11:07+00:00","mainEntityOfPage":{"@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/deelnemen-aan-onderzoek\/"},"wordCount":254,"publisher":{"@id":"https:\/\/breakthrought1d.eu\/nl\/#organization"},"image":{"@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/deelnemen-aan-onderzoek\/#primaryimage"},"thumbnailUrl":"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/09\/shutterstock_298879511-150x150-2.jpg","articleSection":["Archief"],"inLanguage":"nl-NL"},{"@type":"WebPage","@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/deelnemen-aan-onderzoek\/","url":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/deelnemen-aan-onderzoek\/","name":"Deelnemen aan onderzoek - Breakthrough T1D","isPartOf":{"@id":"https:\/\/breakthrought1d.eu\/nl\/#website"},"primaryImageOfPage":{"@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/deelnemen-aan-onderzoek\/#primaryimage"},"image":{"@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/deelnemen-aan-onderzoek\/#primaryimage"},"thumbnailUrl":"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/09\/shutterstock_298879511-150x150-2.jpg","datePublished":"2017-02-13T09:00:00+00:00","dateModified":"2025-05-27T10:11:07+00:00","breadcrumb":{"@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/deelnemen-aan-onderzoek\/#breadcrumb"},"inLanguage":"nl-NL","potentialAction":[{"@type":"ReadAction","target":["https:\/\/breakthrought1d.eu\/nl\/nieuws\/deelnemen-aan-onderzoek\/"]}]},{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/deelnemen-aan-onderzoek\/#primaryimage","url":"","contentUrl":""},{"@type":"BreadcrumbList","@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/deelnemen-aan-onderzoek\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/breakthrought1d.eu\/nl\/"},{"@type":"ListItem","position":2,"name":"Deelnemen aan onderzoek"}]},{"@type":"WebSite","@id":"https:\/\/breakthrought1d.eu\/nl\/#website","url":"https:\/\/breakthrought1d.eu\/nl\/","name":"Breakthrough T1D","description":"Wij zetten ons in voor een toekomst zonder T1D","publisher":{"@id":"https:\/\/breakthrought1d.eu\/nl\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/breakthrought1d.eu\/nl\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"nl-NL"},{"@type":"Organization","@id":"https:\/\/breakthrought1d.eu\/nl\/#organization","name":"Breakthrough T1D","url":"https:\/\/breakthrought1d.eu\/nl\/","logo":{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/logo\/image\/","url":"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/11\/BTlogo.png","contentUrl":"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/11\/BTlogo.png","width":330,"height":141,"caption":"Breakthrough T1D"},"image":{"@id":"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/person\/c141fde9814deb17e9eb392bdb6619a6","name":"ylt-admin","image":{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/67a3317a8082bc0f586c2e46f82a1617530cf674f2027a1a7d60fdff63a2c3e8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/67a3317a8082bc0f586c2e46f82a1617530cf674f2027a1a7d60fdff63a2c3e8?s=96&d=mm&r=g","caption":"ylt-admin"},"sameAs":["https:\/\/87.250.144.92"],"url":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/author\/ylt-admin\/"}]}},"_links":{"self":[{"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/posts\/5989","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/comments?post=5989"}],"version-history":[{"count":5,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/posts\/5989\/revisions"}],"predecessor-version":[{"id":10040,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/posts\/5989\/revisions\/10040"}],"wp:attachment":[{"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/media?parent=5989"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/categories?post=5989"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/tags?post=5989"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}